Cited 6 times in
Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1-High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.